Effects of Alcohol on Release Characteristics of Metformin Hydrochloride Extended-Release Tablets in Vitro and in Vivo
GONG Xiao-fei1,2, ZHANG Dan1, WANG Yi-ran1,2, ZHANG Yi-ping1,2, ZHANG Jin-lan1, CHEN Tai-biao3, XIA Xue-jun1,2*
1. Institute of Materia Medica Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; 2. Beijing Key Laboratory of Drug Delivery Technology and Novel Formulations, Beijing 100050, China; 3. The Place Pharmaceutical (Jiangsu) Co., Ltd., Yancheng 224100, China
Abstract��OBJECTIVE To investigate the effects of alcohol on release characteristics of metformin hydrochloride extended-release tablets in vitro and in vivo. METHODS The release behaviors and swelling of self-made metformin hydrochloride extended-release tablets and commercial products Glucophage XR in different release media including water, 5% alcohol, 20% alcohol and 40% alcohol were investigated and similar factor method was used to evaluate the similarity of release. Based on results in vitro, water and the alcoholic medium with significant differences were selected for Beagle dogs experiments to investigate further the effects of alcohol on release characteristics of metformin hydrochloride extended-release tablets in vivo. RESULTS Along with the increase of the alcohol concentration in the release media, both formation rate of the gel layer became slower and the penetration of the solvents became less in the swelling process, only dissolving a small amount of drug, so the release of self-made tablets and Glucophage XR gradually decreased in vitro. Both release in 40% alcohol produced a significant difference compared with that in water (f2<50), but the release of self-made tablets was greatly similar to Glucophage XR in the same media.In vivo studies of Beagle dogs revealed that an initial low release of both preparations was observed in 40% alcohol which was consistent with the vitro, while a certain increase was observed later, but the overall release was not statistically different from that of the water supply group. Moreover,the main pharmacokinetic parameters of the self-made tablets and Glucophage XR between the water-supply group and the 40% alcohol-supply group had no statistical difference. CONCLUSION Alcohol has the same effects on the release characteristics of self-made metformin hydrochloride extended-release tablets and Glucophage XR in vitro and in vivo. High concentration of alcohol has a significant effect on the release characteristics in vitro, but it has no significant effect on the overall release in vivo.
������, �ŵ�, ��һȻ, ��һƽ, �Ž���, ��̫��, ��ѧ��. �Ҵ����������˫�һ���Ƭ��������ҩ���Ե�Ӱ��[J]. �й�ҩѧ��־, 2019, 54(1): 47-52.
GONG Xiao-fei, ZHANG Dan, WANG Yi-ran, ZHANG Yi-ping, ZHANG Jin-lan, CHEN Tai-biao, XIA Xue-jun. Effects of Alcohol on Release Characteristics of Metformin Hydrochloride Extended-Release Tablets in Vitro and in Vivo. Chinese Pharmaceutical Journal, 2019, 54(1): 47-52.
ROTH W, SETNIK B, ZIETSCH M, et al. Ethanol effects on drug release from verapamil meltrex, an innovative melt extruded formulation [J]. Int J Pharm, 2009, 368(1-2):72-75.
[2]
PALMER D, LEVINA M, FARRELL T P, et al. The influence of hydro-alcoholic media on drug release from polyethylene oxide extended-release matrix tablets [J]. Pharm Technol Eur, 2011, 23(7):16-25.
[3]
WALDEN M, NICHOLLS F A, SMITH K J, et al. The effect of ethanol on the release of opioids from oral prolonged-release preparations [J]. Drug Develop Ind Pharm, 2007, 33(10):1101-1111.
[4]
WANG B, ZHANG L H, LI Y X, et al. Progress on evaluation methods for release mechanism of hydrophlic Gel natrix sustained-release tablets [J]. Chin J Pharm(�й�ҽҩ��ҵ��־), 2009, 40(10):782-786.
[5]
BLOMDE L, DAILEY G E, JABBOUR S A, et al. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study [J]. Curr Med Res Opin, 2004, 20(4):565-572.
[6]
JI L N, CHEN Y L, GAO L L, et al. Randomized controlled clinical study of metformin hydrochloride extended release tablets in the treatment of type 2 diabetes mellitus [J]. J China Prescrip Drug(�й�����ҩ), 2006,5(5):64-65.
[7]
FDA Alert for Healthcare Professionals(July 2005):Hydromorphonehydrochloride extended-release capsules (marketed as PalladoneTM) [EB/OL]. [2018-03-21]. http://www.fda.gov/cder/drug/ InfoSheets/HCP/ hydromorphone HCP.
[8]
CENTER FOR DRUG EVALUATION. Technical guidelines for the study of human bioequivalence of chemical drugs with pharmacokinetic parameters as evaluation index[EB/OL]. [2015-11-27]. http://www.cde.org.cn/zdyz.do?method=largePage&id=227.
[9]
DEFRONZO R, FLEMING G A, CHEN K, et al. Metformin-associated lactic acidosis: current perspectives on causes and risk[J]. Metabol Clin Exper, 2016, 65(2):20-29.
[10]
KIM M J, HAN J Y, SHIN J Y, et al. Metformin-associated lactic acidosis: predisposing factors and outcome[J]. Endocrinol Metabol, 2015, 30(1):78-83.
[11]
RAHIM S A, AL-GHAZAWI M, AL-ZOUBI N. Influence of ethanol on swelling and release behaviors of Carbopol-based tablets [J]. Pharm Develop Technol, 2013, 18(5):1089-1100.
[12]
ROBERTS M, CESPI M J, DAYS A, et al. Influence of ethanol on aspirin release form hypromellose matrices[J]. Int J Pharm, 2007,332(1):31-37.
2019, Vol. 54 
